Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

NAFTIFINE HCL 2% GEL

Naftifine Hydrochloride
$8.5652per GM

Strength

20 mg/g

Manufacturer

Sun Pharmaceutical Industries Inc.

NDC

51672137603

Classification

Generic

Dosage Form

GEL

Route

TOPICAL

Last Updated

3/18/2026

Active Ingredients

NAFTIFINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA208201

On Market Since

4/1/2023

Pharmacological Classes

Allylamine Antifungal
Allylamine

Price History

1W

0.0%

1M

0.0%

3M

+2.4%

6M

+9.5%

1Y

+17.9%

3Y

N/A

5Y

N/A

All

-0.2%

Generic Alternatives

Save up to 77%

1 alternative • Same active ingredient

NAFTIFINE HCL 2% CREAM
Generic
51672136806•Sun Pharmaceutical Industries Inc.
$1.9779
Save 77%

Related Drugs

Same classification

TERBINAFINE HCL 250 MG TABLET
Generic
16714079501•NorthStar Rx LLC
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
16714079502•NorthStar Rx LLC
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
51991052601•Breckenridge Pharmaceutical Inc.
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
62135057230•Chartwell RX LLC
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
62135057290•Chartwell RX LLC
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
65862007930•Aurobindo Pharma Limited
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
69097085902•Cipla USA Inc.
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
69097085907•Cipla USA Inc.
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
69452035113•Bionpharma Inc.
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
69452035120•Bionpharma Inc.
$0.1409
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy